Overview
NY Biogenesis Park (NYBGP) will be the first integrated and dedicated cell and gene therapy ecosystem in the United States and will catalyze cell and gene therapy research, development, clinical trials, manufacturing, and commercialization in New York. NYBGP will accelerate cell and gene therapy commercialization and distribution, revolutionize advanced therapies and deliver life changing outcomes to patients around the world. Download the brochure for more details.
Key Capabilities
Bioinformatics & Biostatistics
Clinical & Translational Services
Genomics & Proteomics
Preclinical Models & Animal Services
